These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 15683245

  • 1. Impact of N-terminal domains for corticotropin-releasing factor (CRF) receptor-ligand interactions.
    Klose J, Fechner K, Beyermann M, Krause E, Wendt N, Bienert M, Rudolph R, Rothemund S.
    Biochemistry; 2005 Feb 08; 44(5):1614-23. PubMed ID: 15683245
    [Abstract] [Full Text] [Related]

  • 2. Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists.
    Hoare SR, Sullivan SK, Schwarz DA, Ling N, Vale WW, Crowe PD, Grigoriadis DE.
    Biochemistry; 2004 Apr 06; 43(13):3996-4011. PubMed ID: 15049707
    [Abstract] [Full Text] [Related]

  • 3. Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity.
    Hoare SR, Sullivan SK, Fan J, Khongsaly K, Grigoriadis DE.
    Peptides; 2005 Mar 06; 26(3):457-70. PubMed ID: 15652653
    [Abstract] [Full Text] [Related]

  • 4. Photoaffinity cross-linking of the corticotropin-releasing factor receptor type 1 with photoreactive urocortin analogues.
    Kraetke O, Holeran B, Berger H, Escher E, Bienert M, Beyermann M.
    Biochemistry; 2005 Nov 29; 44(47):15569-77. PubMed ID: 16300406
    [Abstract] [Full Text] [Related]

  • 5. Hexa-histidin tag position influences disulfide structure but not binding behavior of in vitro folded N-terminal domain of rat corticotropin-releasing factor receptor type 2a.
    Klose J, Wendt N, Kubald S, Krause E, Fechner K, Beyermann M, Bienert M, Rudolph R, Rothemund S.
    Protein Sci; 2004 Sep 29; 13(9):2470-5. PubMed ID: 15295109
    [Abstract] [Full Text] [Related]

  • 6. Corticotropin-releasing factor, urocortin 1, and their receptors in the mouse spinal cord.
    Korosi A, Kozicz T, Richter J, Veening JG, Olivier B, Roubos EW.
    J Comp Neurol; 2007 Jun 20; 502(6):973-89. PubMed ID: 17444496
    [Abstract] [Full Text] [Related]

  • 7. The three-dimensional structure of the N-terminal domain of corticotropin-releasing factor receptors: sushi domains and the B1 family of G protein-coupled receptors.
    Perrin MH, Grace CR, Riek R, Vale WW.
    Ann N Y Acad Sci; 2006 Jul 20; 1070():105-19. PubMed ID: 16888152
    [Abstract] [Full Text] [Related]

  • 8. Three-amino acid motifs of urocortin II and III determine their CRF receptor subtype selectivity.
    Jahn O, Tezval H, van Werven L, Eckart K, Spiess J.
    Neuropharmacology; 2004 Aug 20; 47(2):233-42. PubMed ID: 15223302
    [Abstract] [Full Text] [Related]

  • 9. Extracellular cysteines of the corticotropin-releasing factor receptor are critical for ligand interaction.
    Qi LJ, Leung AT, Xiong Y, Marx KA, Abou-Samra AB.
    Biochemistry; 1997 Oct 14; 36(41):12442-8. PubMed ID: 9376348
    [Abstract] [Full Text] [Related]

  • 10. Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells.
    Kageyama K, Kimura R, Suga S, Ogawa Y, Suda T, Wakui M.
    Peptides; 2006 Jul 14; 27(7):1814-9. PubMed ID: 16513211
    [Abstract] [Full Text] [Related]

  • 11. Binding differences of human and amphibian corticotropin-releasing factor type 1 (CRF(1)) receptors: identification of amino acids mediating high-affinity astressin binding and functional antagonism.
    Dautzenberg FM, Wille S.
    Regul Pept; 2004 May 15; 118(3):165-73. PubMed ID: 15003833
    [Abstract] [Full Text] [Related]

  • 12. Alanine scanning mutagenesis of the second extracellular loop of type 1 corticotropin-releasing factor receptor revealed residues critical for peptide binding.
    Gkountelias K, Tselios T, Venihaki M, Deraos G, Lazaridis I, Rassouli O, Gravanis A, Liapakis G.
    Mol Pharmacol; 2009 Apr 15; 75(4):793-800. PubMed ID: 19124613
    [Abstract] [Full Text] [Related]

  • 13. Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors.
    Perrin MH, Sutton SW, Cervini LA, Rivier JE, Vale WW.
    J Pharmacol Exp Ther; 1999 Feb 15; 288(2):729-34. PubMed ID: 9918582
    [Abstract] [Full Text] [Related]

  • 14. Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides.
    Behan DP, De Souza EB, Lowry PJ, Potter E, Sawchenko P, Vale WW.
    Front Neuroendocrinol; 1995 Oct 15; 16(4):362-82. PubMed ID: 8557170
    [Abstract] [Full Text] [Related]

  • 15. The binding protein of corticotropin-releasing factor: ligand-binding site and subunit structure.
    Jahn O, Eckart K, Brauns O, Tezval H, Spiess J.
    Proc Natl Acad Sci U S A; 2002 Sep 17; 99(19):12055-60. PubMed ID: 12215497
    [Abstract] [Full Text] [Related]

  • 16. Human urocortin 2, a corticotropin-releasing factor (CRF)2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity.
    Zorrilla EP, Reinhardt LE, Valdez GR, Inoue K, Rivier JE, Vale WW, Koob GF.
    J Pharmacol Exp Ther; 2004 Sep 17; 310(3):1027-34. PubMed ID: 15115804
    [Abstract] [Full Text] [Related]

  • 17. [¹²⁵I]YP20: a novel radioligand specific for the extracellular domain of the CRF₁ receptor.
    Gordon JC, Edwards P, Elmore CS, Lazor LA, Paschetto K, Bostwick R, Sylvester M, Mauger R, Scott C, Aharony D.
    Eur J Pharmacol; 2010 Dec 15; 649(1-3):59-63. PubMed ID: 20854803
    [Abstract] [Full Text] [Related]

  • 18. Determination of tumor necrosis factor binding protein disulfide structure: deviation of the fourth domain structure from the TNFR/NGFR family cysteine-rich region signature.
    Jones MD, Hunt J, Liu JL, Patterson SD, Kohno T, Lu HS.
    Biochemistry; 1997 Dec 02; 36(48):14914-23. PubMed ID: 9398215
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Disulfide structure and N-glycosylation sites of an extracellular domain of granulocyte-colony stimulating factor receptor.
    Haniu M, Horan T, Arakawa T, Le J, Katta V, Hara S, Rohde MF.
    Biochemistry; 1996 Oct 08; 35(40):13040-6. PubMed ID: 8855939
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.